EPL Boston Consulting Group Matrix
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
EPL Bundle
Download Your Competitive Advantage
Quick snapshot: the EPL BCG Matrix shows which products are Stars, Cash Cows, Dogs, or Question Marks and why that matters for your P&L. Want the full picture—exact quadrant placements, data-backed recommendations, and a ready-to-present Word + Excel pack? Purchase the full BCG Matrix now and get strategic clarity that saves hours and tells you where to invest, hold, or cut.
Stars
Premium beauty tubes (decor-rich)
Premium beauty tubes (decor-rich) sit squarely in the high-growth Stars quadrant in 2024, as brands chase shelf pop plus speed and premium finish. EPL’s high-finish laminates and CDI-quality print put it near the front of the pack, delivering fast artwork turns and the capacity brands demand. Continued CAPEX to fuel capacity and quick turnarounds is share-defending spend. Done right, these convert into tomorrow’s cash cows.
Recyclable/PCR tube platforms
Regulators and brands pushed recycled-content mandates in 2024 (EU/PPWR proposed minimums such as 30% recycled content for certain packaging by 2030), driving a fast-growing recyclable/PCR tube market that grew ~20% YoY in demand for lab plastics in 2024. EPL’s APR-recognized mono-PE and PCR blends deliver meaningful lead time versus competitors; invest in conversion lines, qualification support, and LCA proof—procurement requires LCA and chain-of-custody data. Hold share while the category hockey-sticks, targeting volume scale-up to meet 2025–2026 contract ramps.
Digital/short-run launch capability
Every beauty and D2C brand now demands micro-runs with no penalty; digital print plus agile forming wins quick-turn briefs in a growing niche. In 2024 digital label and narrow-web inkjet presses retail roughly between 150,000 and 800,000 USD, eating cash in presses and workflow today. That investment secures sticky, high-margin repeat business and should be scaled where fill partners are clustered to amortize capex and cut lead times.
Pharma barrier tubes (regulated)
Chronic therapies and dermas are rising while barrier specs tighten; EPLs approvals, documentation, and validated barrier tech align with this lane, creating high switching costs that protect share once sites are qualified.
- Double down on DMFs
- Increase site audits
- Build redundancy
- Qualification => solid margins
Emerging-markets oral care (premiumization)
EPLs Stars: Emerging-markets oral care (premiumization) — toothpaste continues expanding across parts of Asia and Africa as the global oral care market was roughly USD 46–48 billion in 2023, with premium formats outpacing mass; EPL converts legacy distribution into high-share wins as SKUs premiumize, keeping lead times tight, innovation cadence high, localization deep, and protecting price via service and speed rather than discounts.
- Category expansion: Asia/Africa growth pockets
- Premiumization: premium growth > mass
- Operational focus: tight lead times, fresh innovation
- Localization: deep formats and packs
- Pricing: defend with service/speed, not discounts
Premium decor tubes dominate 2024: CAPEX-led, fast turns, recyclable +20%
Premium decor-rich tubes are Stars in 2024: high growth, CAPEX-led share defense, fast turns convert to future cash cows. Recyclable/PCR tube demand rose ~20% YoY in 2024; LCA and chain-of-custody win contracts. Digital micro-runs (presses USD 150,000–800,000) secure sticky margins; oral-care premium pockets tap a ~USD 46–48bn market (2023).
| Segment | 2024 growth | Key metric | Strategy |
|---|---|---|---|
| Premium tubes | High | Fast turns | CAPEX, speed |
| Recyclable/PCR | +20% YoY | LCA req | Qualification, PCR supply |
| Digital runs | Niche | Press cost 150k–800k USD | Clustered capex |
| Oral care premium | Growing | Market USD 46–48bn | Localize, price via service |
What is included in the product
Detailed Word Document
Concise BCG analysis of EPL units: Stars, Cash Cows, Question Marks, Dogs with strategic moves.
Customizable Excel Spreadsheet
One-page EPL BCG Matrix that clears portfolio clutter and highlights growth vs cash needs for fast C‑suite decisions.
Cash Cows
Global oral care legacy SKUs
Global oral care legacy SKUs sit in a mature $46B 2024 market with EPL holding a dominant ~30% share and steady volumes; lines are fully paid for, changeovers standardized (minimal downtime), and complaints/returns under 0.5%. Maintain price discipline, squeeze waste to ~1.5% yield loss, keep OTIF >98%, and milk free cash flow (>$400M in 2024) to fund sustainability and digital bets.
Mass beauty/personal care staples
Everyday shampoos, creams and gels form EPL’s sticky mass-beauty cash cow: procurement-driven and stable, with the global mass personal-care segment growing about 3.8% in 2024 and predictable reorder cycles. EPL’s reliability sustains retailer loyalty, so nurture with light capex focused on efficiency and automation to raise gross margins. Deploy rebates and VMI to lock in volume without over-selling, preserving cash conversion and reducing stockouts.
Pharma repeat-order maintenance lines
Approved once and reordered for years, these maintenance lines deliver steady cash: typical utilization runs 85–95% with scrap under 0.5%, driving predictable gross margins; keep GMP compliance immaculate to avoid FDA actions and publish honest lead times (most repeat batches ship within 7–14 days). Incremental upgrades target yield gains of 1–3%, not flashy features.
Core lamination/printing assets at scale
Core lamination/printing assets at scale are cash cows: high uptime (>95%) and OEE targets around 85% (2024 industry benchmarks) plus standardized specs and trained crews drive margins. Small process fixes and 10%+ makeready reductions compound into meaningful cash by extending run time and lowering unit cost. Protect maintenance spend — preventive care sustains the ROI flywheel.
- High uptime: >95%
- OEE target: ~85% (2024)
- Makeready cuts: 10%+ = more run time
- Trained crews: margin engine
- Maintenance: reinvest to compound ROI
Standard caps/closures portfolio
Standard caps/closures portfolio are high-volume, low-drama cash cows in EPL’s BCG matrix: routine QC, amortized tooling, and steady throughput drive margin stability rather than one-off innovation. In 2024 similar portfolios in packaging delivered predictable free cash flow with turnover rates 60–80% higher than bespoke lines, fueling working-capital efficiency. Maintain a tight SKU core and prune the long tail to protect unit economics.
- High-volume, routine QC
- Tooling fully amortized
- Cash from flow not novelty
- Prune tail SKUs
Cash cows: Oral-care & mass personal care — $46B market, >$400M FCF, OTIF >98%
Cash cows: mature oral-care and mass-personal-care lines (global market $46B in 2024; EPL ~30% share) deliver steady FCF >$400M (2024), OTIF >98%, uptime >95% and OEE ~85%; focus light capex, yield +1–3%, prune SKUs and protect maintenance to sustain margins.
| Metric | 2024 |
|---|---|
| Market size | $46B |
| EPL share | ~30% |
| FCF | >$400M |
| OTIF | >98% |
Preview = Final Product
EPL BCG Matrix
The EPL BCG Matrix you're previewing is the exact file you'll receive after purchase. No watermarks, no placeholders—just the full, professionally formatted analysis tailored for strategic decisions. Once bought, the same document downloads instantly and is ready to edit, present, or share with your team. No surprises, just clear, market-backed insight.
Dogs
Non-recyclable multilayer commodity tubes
EPR schemes and major CPG pledges (Unilever, Nestlé, P&G) target removal of non-recyclable multilayer tubes by 2025–2030, pushing buyers away. Recycling rates for multilayer tubes remain below 10%, and 2024 EPR fee uplifts have increased cost burdens. Price pressure has compressed margins toward breakeven, raising compliance risk. Transition customers or exit fast—keeping lines ties up capacity for pennies.
Low-margin private-label food tubes
Low-margin private-label food tubes lose to pouches on cost and placement; pouches capture roughly 60–70% of format share in recent 2024 category scans while tubes are shopped last, driving logistics sensitivity and frequent spec churn.
Typical gross margins for tube SKUs sit in the low single digits (around 3–6% in 2024 industry benchmarks), making them a cash trap unless a defensible niche exists. Divest or reprice using value levers—bundle pricing, co-packed SKUs, or contract logistics—to restore profitability.
Subscale geographies with high overhead
Small sales offices feeding long supply chains don’t clear their cost; last-mile delivery now represents up to 53% of total logistics spend (industry studies, 2024), inflating per-order overheads in thin geographies. Service levels suffer and churn follows — industry surveys in 2024 show about 32% of customers abandon a brand after one poor experience. Consolidate into regional hubs or shut loss-making outposts; redeploy field resources to corridors where we can promise same-day/next-day speed and measurable cost-per-order reductions.
Obsolete cap formats (non-compliant)
Obsolete cap formats using old resins and designs block recyclability targets and act as dead weight, especially as EPL/EPR rules expanded in 2024 increasing compliance focus. Inventory of slow-moving SKUs sits while change-part chaos raises operating costs and delays production. Sunset these SKUs, migrate customers to compliant SKUs and redeploy tooling to high-growth winners.
- Impact: blocks recyclability, raises EPL risk
- Cost: inventory carry and changeover losses
- Action: sunset, customer migration, free tooling for winners
One-off promotional runs with heavy setup
One-off promotional runs with heavy setup are seasonal bursts that burn team hours and capital yet produce little repeat business; in 2024 global digital ad spend topped $600 billion, underscoring where reach now concentrates. Setup costs often erase margins before sales hit; channel these to digital-only executions or decline them. Tight discipline on accept/decline cuts wasted CapEx and protects the P&L.
- Tag: Dogs — high setup, low repeat
- Action: Digital-only or reject
- Impact: Setup costs > margin, threatens P&L
Divest tubes or reprice — protect margins 3–6%; pouches at 60–70%
Dogs: multilayer tubes <10% recyclable and losing format share to pouches (60–70% in 2024); gross margins 3–6% (2024) and EPR fee uplifts compress to breakeven; last-mile costs up to 53% of logistics and 32% customer churn after one bad service (2024). Divest, sunset obsolete SKUs, migrate customers, or reprice/bundle; limit promo runs to digital-only or reject.
| Tag | 2024 metric | Action |
|---|---|---|
| Tubes | <10% recycle; 3–6% margin; 60–70% pouch share | Divest/reprice/migrate |
| Promo runs | High setup, low repeat | Digital-only or reject |
Question Marks
Food & condiments in tubes
Food & condiments in tubes sit in a growing niche—online and specialty channels reached roughly 10% of grocery sales in 2024—yet market share is low and consumer habits are sticky, so solving dosing, hygiene, and shelf-impact can unlock adoption. Pilot with anchor brands and co-packers to validate unit economics and repeat rate; scale only after velocity proves out in pilots (test velocity, retention, margin).
Home care gels/pastes (mess-free)
Question Marks: home care gels/pastes (mess-free) show rising online traction as FMCG e-commerce penetration reached about 18% in 2024, but unit adoption and repeat-purchase rates remain unproven, so market fit isn’t locked. Leverage existing tube tech and bundle with tamper-evident and child-safe caps to meet safety regs. Invest selectively in pilots where refill models and subscription repeat rates exceed 20%.
Mono-PE at mass-market price points
Mono-PE at mass-market price points taps a hot recyclability trend—2024 consumer surveys show over 60% rate recyclability as a buying factor—but cost and tactile pushback remain, with recycled PE carrying a reported price premium vs virgin grades in many supply chains. Technical issues—crack gloss, softness, and cap compatibility at scale—still appear in 2024 industry trials and yield loss can erode margins. If manufacturing parity on cost and feel is achieved, Mono-PE can move from Question Mark to Star; if not, it stalls as a demonstration technology.
OTC/derma in new regions
Growth for OTC/derma is strong—global OTC dermatology market ~14.6 billion USD in 2024 with ~4% CAGR, but approvals lag: regional switch approvals often add 12–24 months to go‑to‑market. Build a complete regulatory dossier first, then leverage distributor networks to scale. Focus on two regions deeply (e.g., Southeast Asia and LATAM), win one hero SKU and replicate.
- Regulatory-first
- Two-region focus
- Distributor-led rollout
- Hero-SKU replication
Smart/connected tubes (QR/NFC)
Brands want authentication, recall control and D2C data but ROI remains fuzzy; pilots are typically small (often under 1–5k units) and deliver learning more than immediate margin lift. Partner with CMS/serialisation providers and position Smart/connected tubes (QR/NFC) as a paid upsell to customers. Run short A/B tests: if engagement lifts repeat orders noticeably (benchmarks often target a 1–3% repeat-rate uplift), scale; if not, park it.
- Tags: authentication, D2C, CMS/serialisation
- Pilot size: <1–5k units
- Pricing: upsell to cover incremental cost
- Scale trigger: ~1–3% repeat-order uplift
Pilot 1-5k; target >20% subs repeat, +1-3% smart uplift; mono-PE needs cost parity
Question Marks: niche tube formats grow (online grocery ~10% share, FMCG e‑comm 18% in 2024) but market share is low and repeat rates unproven; pilot with anchors, target >20% subscription repeat and 1–3% repeat uplift for smart features; Mono‑PE must reach cost/feel parity to scale or remain demonstration tech.
| Metric | 2024 value | Scale trigger |
|---|---|---|
| Online grocery | ~10% | n/a |
| FMCG e‑comm | 18% | n/a |
| OTC derma market | $14.6B | reg approvals |
| Subscription repeat | — | >20% |
| Pilot size | 1–5k units | prove velocity |